M&T Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
M&T Bank's VRTX Position: Q2 2026 in Review
M&T Bank increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, buying an estimated $133K and bringing the position to 13,959 shares worth $6.93M. The position accounts for 0.02% of the portfolio, ranked #343.
M&T Bank first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.1M in Q4 2023. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- M&T Bank held 13,959 shares of Vertex Pharmaceuticals worth $6.93M as of Q2 2026.
- M&T Bank bought 299 Vertex Pharmaceuticals shares in Q2 2026, an estimated $133K.
- Vertex Pharmaceuticals made up 0.02% of M&T Bank's portfolio in Q2 2026, its #343 holding.
- M&T Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- M&T Bank's Vertex Pharmaceuticals position peaked at $19.1M in Q4 2023.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.